𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Quality of Methods for Assessing and Reporting Serious Adverse Events in Clinical Trials of Cancer Drugs

✍ Scribed by Belknap, S M; Georgopoulos, C H; West, D P; Yarnold, P R; Kelly, W N

Book ID
109846310
Publisher
Nature Publishing Group
Year
2010
Tongue
English
Weight
133 KB
Volume
88
Category
Article
ISSN
0009-9236

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Missing quality of life data in cancer c
Missing quality of life data in cancer clinical trials: serious problems and challenges
✍ JΓΌrg Bernhard; David F. Cella; Alan S. Coates; Lesley Fallowfield; Patricia A. G πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 173 KB πŸ‘ 2 views

Measurement of quality of life (QOL) in cancer clinical trials has increased in recent years as more groups realize the importance of such endpoints. A key problem has been missing data. Some QOL data may unavoidably be missing, as for example when patients are too ill to complete forms. Other impor